Laëtitia Largeaud (Laetitia Largeaud)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Acute Myeloid Leukemia

Dendritic Cells

Tyrosine Kinase

Top Venues

The Journal of experimental medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Pierre Luc Mouchel, Emilie Bérard, Suzanne Tavitian, Noémie Gadaud, François Vergez, Jean Baptiste Rieu, Isabelle Luquet, Audrey Sarry, Françoise Huguet, Laëtitia Largeaud, Eric Delabesse, Anne Huynh, Sarah Bertoli, Christian Recher
Vitamin C and D Supplementation in Acute Myeloid Leukemia. Blood advances (2023)
Vincent Fregona, Manon Bayet, Mathieu Bouttier, Laëtitia Largeaud, Camille Hamelle, Laura Audrey Jamrog, Naïs Prade, Stéphanie Lagarde, Sylvie Hebrard, Isabelle Luquet, Véronique De Mas, Marie Nolla, Marlène Pasquet, Christine Didier, Ahmed Amine Khamlichi, Cyril Broccardo, Eric Delabesse, Stéphane J C Mancini, Bastien Gerby
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL. The Journal of experimental medicine 221 (1) (2023)
Alban Canali, Inès Vergnolle, Sarah Bertoli, Laëtitia Largeaud, Marie-Laure Nicolau, Jean Baptiste Rieu, Suzanne Tavitian, Françoise Huguet, Muriel Picard, Pierre Bories, Jean-Philippe Vial, Nicolas Lechevalier, Marie Christine Bene, Isabelle Luquet, Véronique De Mas, Eric Delabesse, Christian Recher, François Vergez
Prognostic impact of unsupervised early assessment of bulk and leukemic stem cell measurable residual disease in acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Nicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, Rathana Kim, Julie Rieunier, Juliette Lambert, Audrey Bidet, Lise Larcher, Jean Lemoine, François Delhommeau, Pierre Hirsch, Laurène Fenwarth, Olivier Kosmider, Justine Decroocq, Anne Bouvier, Yannick Le Bris, Marlène Ochmann, Alberto Santagostino, Lionel Ades, Pierre Fenaux, Xavier Thomas, Jean-Baptiste Micol, Claude Gardin, Raphaël A Itzykson, Jean Soulier, Emmanuelle Clappier, Christian Recher, Claude Preudhomme, Arnaud Pigneux, Hervé Dombret, Eric Delabesse, Marie Sébert
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study. Blood 140 (7) (2022)
Lucie Coster, Véronique De Mas, Laëtitia Largeaud, Sophie Voisin, Jill Corre, Martin Gauthier
Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR-ABL1 detection failure using RT-MLPA (positive RT-qPCR). EJHaem 2 (3) (2021)
Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, Laëtitia Largeaud, Vincent Fregona, Nais Prade, Pierre-Yves Juvin, Laura Audrey Jamrog, Pierre Bories, Sylvie Hébrard, Stéphanie Lagarde, Veronique Mansat-De Mas, Oliver M Dovey, Kosuke Yusa, George S Vassiliou, Joop H Jansen, Tobias Tekath, David Rombaut, Geneviève Ameye, Carole Barin, Audrey Bidet, John Boudjarane, Marie-Agnès Collonge-Rame, Carine Gervais, Antoine Ittel, Christine Lefebvre, Isabelle Luquet, Lucienne Michaux, Nathalie Nadal, Helene A Poirel, Isabelle Radford-Weiss, Benedicte Ribourtout, Steven Richebourg, Stephanie Struski, Christine Terré, Isabelle Tigaud, Dominique Penther, Virginie Eclache, Michaela Fontenay, Cyril Broccardo, Eric Delabesse
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11. Blood advances (2021)
Preeti Singh, Maninder Heer, Anastasia Resteu, Aneta Mikulasova, Mojgan Reza, Laëtitia Largeaud, Stephanie Dufrechou, Nais Prade, Rachel E Dickinson, Jacinta Bustamante, Bénédicte Neven, Venetia Bigley, Eric Delabesse, Daniel Rico, Marlène Pasquet, Matthew Collin
GATA2 deficiency phenotype associated with tandem duplication GATA2 and over-expression of GATA2-AS1. Blood advances (2021)